Naveen Yarlagadda Selected Research

Naveen Yarlagadda Research Topics

2	Multiple Myeloma 01/2022 - 11/2021
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Residual Neoplasm 01/2022
1	Dysarthria (Spastic Dysarthria) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 05/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2014
1	Neoplasm Metastasis (Metastasis) 08/2013
1	Prostatic Neoplasms (Prostate Cancer) 08/2013

2	Monoclonal AntibodiesIBA 11/2021 - 01/2020
2	NivolumabIBA 01/2020 - 01/2020
1	ADP-ribosyl Cyclase 1IBA 11/2021
1	pembrolizumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	encorafenibIBA 01/2018
1	binimetinibIBA 01/2018
1	cobimetinibIBA 01/2018
1	dabrafenibIBA 01/2018
1	trametinibIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	VemurafenibIBA 01/2018
1	Interleukin-2 (IL2)IBA 05/2014
1	Docetaxel (Taxotere)FDA Link 08/2013
1	cabazitaxel FDA Link 08/2013
1	Prednisone (Sone)FDA LinkGeneric 08/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2013